APAC Hepatocellular Carcinoma (HCC) Leadership & Policy Forum 2025

The APAC HCC Leadership & Policy Forum 2025, co-hosted by the Taiwan Health Promotion Administration (HPA), the Taiwan National Health Insurance Administration (NHIA) and the APAC Liver Disease Alliance in June 2025, brought together policymakers, clinicians, academics, and patient advocates from across the Asia-Pacific region.

The Forum focused on advancing strategies for the prevention, early detection, and management of hepatocellular carcinoma (HCC), fostering collaboration between governments and healthcare stakeholders to accelerate progress toward improved patient outcomes.

This report summarises key discussions, policy recommendations, and commitments made to strengthen regional action against HCC.

 

Photo gallery

Next
Next

Hepatitis and HCC in APAC - Infographic 2025